HK1222211A1 - 生物組織分散用組合物 - Google Patents

生物組織分散用組合物

Info

Publication number
HK1222211A1
HK1222211A1 HK16110451.3A HK16110451A HK1222211A1 HK 1222211 A1 HK1222211 A1 HK 1222211A1 HK 16110451 A HK16110451 A HK 16110451A HK 1222211 A1 HK1222211 A1 HK 1222211A1
Authority
HK
Hong Kong
Prior art keywords
composition
biological tissue
dispersing
dispersing biological
tissue
Prior art date
Application number
HK16110451.3A
Other languages
English (en)
Inventor
宫川功
河村聖子
小林昶運
Original Assignee
Kurashiki Boseki Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurashiki Boseki Kk filed Critical Kurashiki Boseki Kk
Publication of HK1222211A1 publication Critical patent/HK1222211A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK16110451.3A 2013-11-12 2016-09-02 生物組織分散用組合物 HK1222211A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013234036A JP2015092852A (ja) 2013-11-12 2013-11-12 生体組織分散用組成物
PCT/JP2014/077356 WO2015072266A1 (ja) 2013-11-12 2014-10-14 生体組織分散用組成物

Publications (1)

Publication Number Publication Date
HK1222211A1 true HK1222211A1 (zh) 2017-06-23

Family

ID=53057208

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110451.3A HK1222211A1 (zh) 2013-11-12 2016-09-02 生物組織分散用組合物

Country Status (7)

Country Link
US (1) US20160289662A1 (zh)
JP (1) JP2015092852A (zh)
CN (1) CN105705651A (zh)
CA (1) CA2929682A1 (zh)
HK (1) HK1222211A1 (zh)
TW (1) TW201520223A (zh)
WO (1) WO2015072266A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI733927B (zh) * 2016-11-01 2021-07-21 日商倉敷紡績股份有限公司 細胞測定方法
WO2019054468A1 (ja) * 2017-09-15 2019-03-21 株式会社カネカ 細胞含有試料からの細胞の遊離方法
JP7430895B2 (ja) * 2019-08-06 2024-02-14 学校法人東北工業大学 ハイドロゲル構造体の製造方法並びにそのハイドロゲル構造体を利用した生物試料の培養方法及び分析方法
CN113403295A (zh) * 2021-06-07 2021-09-17 山西省人民医院 一种制备人肾脏组织单细胞悬液的消化酶及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
DE69430054T2 (de) * 1993-12-30 2002-10-24 Nitta Gelatin Kk Verfahren zum einbetten von tierkulturzellen
JP3222785B2 (ja) * 1996-10-11 2001-10-29 新田ゼラチン株式会社 癌細胞の定量測定方法
AU9260598A (en) * 1997-08-22 1999-03-16 Boehringer Mannheim Gmbh Zymogenic protease precursors that can be autocatalytically activated and their use
JP3363445B1 (ja) * 2001-04-23 2003-01-08 新田ゼラチン株式会社 生検採取細胞の培養方法および動物細胞培養用キット
CN1910275B (zh) * 2003-12-01 2011-04-27 威特克斯医药股份有限公司 包含胎儿肝细胞的组合物及其用于hcv感染的方法
US20070238175A1 (en) * 2006-04-06 2007-10-11 Chi Alfred L Standardization of processes for culturing primary cells
JP2007291034A (ja) * 2006-04-26 2007-11-08 Osaka Univ 新規酵素阻害剤
EP2421959A1 (en) * 2009-04-23 2012-02-29 Cytori Therapeutics, Inc. Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney

Also Published As

Publication number Publication date
CN105705651A (zh) 2016-06-22
WO2015072266A1 (ja) 2015-05-21
TW201520223A (zh) 2015-06-01
US20160289662A1 (en) 2016-10-06
JP2015092852A (ja) 2015-05-18
CA2929682A1 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
ZA201503370B (en) Composition comprising biological control agents
IL243599A0 (en) surgical implant
IL240398A0 (en) surgical implant
IL240349B (en) surgical implant
IL240534A0 (en) surgical implant
GB201300165D0 (en) Surgical instrument
ZA201503911B (en) Surgical instrument
SG11201405478VA (en) Stabilizing composition for biological materials
ZA201501852B (en) An improved surgical template
GB201322237D0 (en) Surgical reamer
HK1203857A1 (zh) 生物組織的處理方法
GB2516051B (en) Surgical tables
IL245647A0 (en) surgical gauze
EP2892437A4 (en) IMPROVED SURGICAL INSTRUMENT
EP2975408A4 (en) assay kit
EP3073929A4 (en) Improvement for mammography examinations
EP3034101A4 (en) Biological implant
EP2939618A4 (en) SURGICAL INSTRUMENT
HK1222211A1 (zh) 生物組織分散用組合物
HK1204947A1 (zh) 滅菌組合物
IL233864B (en) bone screw
EP2975407A4 (en) EXAM KIT
AU353710S (en) Surgical handle
GB201414619D0 (en) Disinfectant composition
GB201307200D0 (en) Tissue culture system